Immix Biopharma Inc (IMMX) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Immix Biopharma Inc   (NASDAQ: IMMX)


Immix Biopharma Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Immix Biopharma Inc's ROI in the second quarter of 2026?
Immix Biopharma Inc recorded a cumulative net loss of $-40 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -38.1%.

Within the Healthcare sector 102 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3588 to 3813.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 754.36 % 185.07 % 39.44 % -54.84 % -44.81 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 230 85 95 9 6
Return On Investment (TTM) -38.1 % -71.81 % -97.99 % -237.4 % -188.6 %
IMMX's Overall Ranking # 3813 # 3588 # 3597 # 3876 # 3471
Seq. Investment Change TTM 115.05 % 62.16 % 202.69 % -19.06 % -28.25 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -40 -35 -29 -24 -23

IMMX Company Profile >> Back to IMMX Roi Comparisons >> See Annual IMMX Return On Investment



Return On Investment IMMX's Ranking
Within: No.
Industry # 27
Sector # 103
Overall # 3813

Return On Investment Statistics
High Average Low
-38.1 %
-102.31 %
-237.4 %
(Jun 30 2026)   (Sep 30 2025)







Financial Statements
Immix Biopharma Inc's II. Quarter Investments $ 230 Millions IMMX's Balance sheet
Immix Biopharma Inc's II. Quarter Income $ -12 Millions Quarterly IMMX's Income Statement
IMMX's Income by Division See IMMX's Income by Division


IMMX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 95 14 16 14 18
Y / Y Investment Growth 564.27 % -10.88 % 17.36 % -24.21 % -
Net Income in Millions -29 -22 -16 -8 -24
Y / Y Net Income Growth - - - - -
Annual Return On Investment -31.08 % -152.15 % -97.46 % -60.36 % -135.54 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IMMX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IMMX's Competitors
Subscribers only: Roi for Immix Biopharma Inc's Suppliers
Subscribers only: Return On Investment for IMMX's Customers

Other Ratios
IMMX's Roa IMMX's Inventory Turnover Ratio IMMX's Growth Rates IMMX's Dividend Statistics
IMMX's Profitability Ratios IMMX's Asset Turnover Ratio IMMX's Dividend Growth
IMMX's Roe IMMX's Valuation Ratios IMMX's Financial Strength Ratios IMMX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:41:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.